HCA Healthcare, Inc. $HCA Shares Acquired by Cibc World Market Inc.

Cibc World Market Inc. raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 21.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,174 shares of the company’s stock after buying an additional 6,322 shares during the period. Cibc World Market Inc.’s holdings in HCA Healthcare were worth $15,417,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Caprock Group LLC purchased a new stake in HCA Healthcare during the third quarter worth approximately $5,694,000. ING Groep NV acquired a new stake in shares of HCA Healthcare during the third quarter worth about $1,025,000. Krilogy Financial LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $890,000. Advisors Asset Management Inc. increased its position in HCA Healthcare by 13.3% during the third quarter. Advisors Asset Management Inc. now owns 6,337 shares of the company’s stock worth $2,701,000 after buying an additional 743 shares during the period. Finally, Versor Investments LP grew its position in shares of HCA Healthcare by 10.0% during the third quarter. Versor Investments LP now owns 1,699 shares of the company’s stock worth $724,000 after acquiring an additional 154 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised FY-2026 EPS to $29.31 (from $28.47) and lifted multiple quarterly and multi‑year estimates (FY2027 to $33.44, FY2028 to $37.67), aligning analyst expectations with HCA’s FY2026 guidance and suggesting stronger forward profitability. Zacks remains at a “Hold” rating, but the higher estimates support valuation and earnings momentum. Zacks estimate changes (MarketBeat)
• Neutral Sentiment: HCA’s StoneSprings Hospital Center is planning to convert a Chantilly deli site into a freestanding emergency room — a local expansion that could modestly increase patient volumes and admissions in that market over time. HCA StoneSprings freestanding ER
• Neutral Sentiment: HCA-related ASC real estate was sold, a move that can free capital or change lease/operating dynamics for ambulatory surgery centers; the net effect depends on deal terms and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: Executive moves: a former HCA Florida executive joined Memorial Health as COO and an HCA veteran was named COO at Memorial Health in Georgia — routine industry leadership turnover that may have limited near‑term impact on HCA’s financials but is notable for regional competitive dynamics and management talent flow. Former HCA exec joins Memorial Health (MSN) HCA veteran named COO (Becker’s)

HCA Healthcare Stock Up 0.7%

NYSE:HCA opened at $535.24 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $552.90. The firm’s fifty day simple moving average is $481.73 and its 200-day simple moving average is $446.85. The stock has a market cap of $119.69 billion, a PE ratio of 18.86, a price-to-earnings-growth ratio of 1.63 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HCA. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price on the stock. in a research note on Monday, December 15th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a report on Monday, October 27th. Finally, UBS Group upped their price objective on shares of HCA Healthcare from $525.00 to $598.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $523.27.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 13,520 shares of company stock valued at $6,894,067. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.